ClinConnect ClinConnect Logo
Search / Trial NCT06637839

Optimal Dosing of High-Intensity Locomotor Training for Step Attainment and Locomotor Outcomes in Stroke Patients Undergoing Acute Inpatient Rehabilitation

Launched by NYU LANGONE HEALTH · Oct 10, 2024

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the best way to use High-Intensity Gait Training (HIGT) to help patients who have had a stroke improve their walking abilities during their recovery in a rehabilitation facility. The goal is to find out how much training is most effective for reducing difficulties with movement in patients who are in the early stages of stroke recovery. Participants will be randomly assigned to one of two different training programs or a program that focuses on increasing their step count while they receive standard care.

To be eligible for this trial, participants must have had a stroke as their primary diagnosis. However, individuals who have certain health issues that could prevent them from participating in physical activity, those who are expected to stay in the hospital for less than 14 days, or those who were unable to walk more than 50 meters before their hospital admission cannot take part. The trial is not yet recruiting participants, but it aims to gather valuable information that could help improve rehabilitation methods for stroke patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Primary diagnosis of stroke
  • Exclusion Criteria:
  • Weightbearing restrictions, uncontrolled cardiopulmonary, metabolic, infectious, or psychiatric disorders, which would preclude aerobic locomotor training
  • Estimated length of stay of less than 14 days
  • Non-ambulatory status prior to admission (unable to walk \>50 meters)
  • Pregnant

About Nyu Langone Health

NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Susan Camillieri

Principal Investigator

NYU Langone Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported